Compound Info
NAs Base Info
ID Cluster Name Target MolWt
Compound Structure
NAs.000052 7
Target name Tax id
Adenosine A2a receptor 9606.0
GABA transporter 1 9606.0
Serotonin 2c (5-HT2c) receptor 9606.0
Serotonin 2a (5-HT2a) receptor 9606.0
Muscarinic acetylcholine receptor M5 9606.0
Dopamine transporter 9606.0
Beta-2 adrenergic receptor 9606.0
Histamine H1 receptor 9606.0
Opioid receptors; mu/kappa/delta 9606.0
Dopamine D2 receptor 9606.0
Serotonin 4 (5-HT4) receptor 9606.0
Muscarinic acetylcholine receptor M3 9606.0
Equilibrative nucleoside transporter 1 9606.0
Glutamate receptor ionotropic AMPA 9606.0
GABA-A receptor; anion channel 9606.0
Serotonin 6 (5-HT6) receptor 9606.0
Muscarinic acetylcholine receptor M4 9606.0
Dopamine D1 receptor 9606.0
Adenosine receptors; A2a & A2b 9606.0
GABA-B receptor 9606.0
Glutamate receptor ionotropic kainate 9606.0
Adenosine A2b receptor 9606.0
Serotonin 3 (5-HT3) receptor 9606.0
Dopamine D4 receptor 9606.0
Dopamine D5 receptor 9606.0
Adrenergic receptor alpha-1 9606.0
Adenosine A1 receptor 9606.0
Norepinephrine transporter 9606.0
Serotonin transporter 9606.0
Glutamate [NMDA] receptor 9606.0
Beta-1 adrenergic receptor 9606.0
Serotonin 5a (5-HT5a) receptor 9606.0
Dopamine D3 receptor 9606.0
Adenosine receptors; A1 & A2a 9606.0
Adrenergic receptor alpha-2 9606.0
Vesicular acetylcholine transporter 9606.0
Muscarinic acetylcholine receptor M1 9606.0
Muscarinic acetylcholine receptor M2 9606.0
Adenosine A3 receptor 9606.0
Serotonin 1a (5-HT1a) receptor 9606.0
286.343
Chemical Representations
InChI InChI=1S/C13H18N8/c1-3-4-5-6-9-17-11(14)10-12(18-9)20(2)13(19-10)21-15-7-8-16-21/h7-8H,3-6H2,1-2H3,(H2,14,17,18)
InChI Key PYUBHJHQYILWFE-UHFFFAOYSA-N
SMILES CCCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1
Molecular Formula C13H18N8
Functional Fragments
Base Ribose Phosphate
Base Structure
Unmatch
No Image Available
Match
Calculated Properties
logP 1.259 Computed by RDKit
Heavy Atom Count 21 Computed by RDKit
Ring Count 3 Computed by RDKit
Hydrogen Bond Acceptor Count 8 Computed by RDKit
Hydrogen Bond Donor Count 1 Computed by RDKit
Rotatable Bond Count 5 Computed by RDKit
Topological Polar Surface Area 100.330 Computed by RDKit
Activity Data
Target Activity type Relation Value Unit Assay Source
Adenosine A2a receptor Ki = 3.3 nM Binding affinity towards human Adenosine A2a receptor expressed in HEK293 cells using 6 nM [3H]CGS-21680 CHEMBL1140374
Beta-2 adrenergic receptor Inhibition < 10.0 % Percent inhibition against Beta-2 adrenergic receptor at 1 uM CHEMBL1140374
GABA-A receptor; anion channel Inhibition < 10.0 % Percent inhibition against central Benzodiazepine receptor at 1 uM CHEMBL1140374
Dopamine D1 receptor Inhibition < 10.0 % Percent inhibition against Dopamine receptor D1 at 1 uM CHEMBL1140374
Dopamine D2 receptor Inhibition < 10.0 % Percent inhibition against Dopamine receptor D2 at 1 uM CHEMBL1140374
Dopamine D3 receptor Inhibition < 10.0 % Percent inhibition against Dopamine receptor D3 at 1 uM CHEMBL1140374
Dopamine D4 receptor Inhibition < 10.0 % Percent inhibition against Dopamine receptor D4 at 1 uM CHEMBL1140374
Dopamine D5 receptor Inhibition < 10.0 % Percent inhibition against Dopamine receptor D5 at 1 uM CHEMBL1140374
GABA-A receptor; anion channel Inhibition < 10.0 % Percent inhibition against GABAA receptor alpha at a compound concentration of 1 uM CHEMBL1140374
GABA-B receptor Inhibition < 10.0 % Percent inhibition against GABA-B receptor at 1 uM CHEMBL1140374
GABA transporter 1 Inhibition < 10.0 % Percent inhibition against GABA transporter at a compound concentration of 1 uM CHEMBL1140374
Adenosine receptors; A2a & A2b Selectivity = 45.81 Selective binding affinity towards human Adenosine A2b receptor expressed in HEK293 cells using [3H]-DPCPX compared to human Adenosine A2a receptor expressed in HEK293 cells using [3H]CGS-21680 CHEMBL1140374
Glutamate receptor ionotropic AMPA Inhibition < 10.0 % Percent inhibition against AMPA receptor at 1 uM CHEMBL1140374
Glutamate receptor ionotropic kainate Inhibition < 10.0 % Percent inhibition against Kainate receptor at a compound concentration of 1 uM CHEMBL1140374
Glutamate [NMDA] receptor Inhibition < 10.0 % Percent inhibition against PCP receptor at 1 uM CHEMBL1140374
Unchecked Inhibition < 10.0 % Percent inhibition against P2X Purinergic receptor at 1 uM CHEMBL1140374
Unchecked Inhibition < 10.0 % Percent inhibition against P2Y Purinoceptor at 1 uM CHEMBL1140374
Glutamate [NMDA] receptor Inhibition < 10.0 % Percent inhibition against NMDA receptor at a compound concentration of 1 uM CHEMBL1140374
Histamine H1 receptor Inhibition < 10.0 % Percent inhibition against Histamine H1 receptor at 1 uM CHEMBL1140374
Muscarinic acetylcholine receptor M1 Inhibition < 10.0 % Percent inhibition against Muscarinic acetylcholine receptor M1 at 1 uM CHEMBL1140374
Muscarinic acetylcholine receptor M2 Inhibition < 10.0 % Percent inhibition against Muscarinic acetylcholine receptor M2 at 1 uM CHEMBL1140374
Muscarinic acetylcholine receptor M3 Inhibition < 10.0 % Percent inhibition against Muscarinic acetylcholine receptor M3 at 1 uM CHEMBL1140374
Adenosine A2b receptor Ki = 153.0 nM Binding affinity towards human Adenosine A2b receptor expressed in HEK293 cells using 5 nM [3H]DPCPX CHEMBL1140374
Muscarinic acetylcholine receptor M4 Inhibition < 10.0 % Percent inhibition against Muscarinic acetylcholine receptor M4 at 1 uM CHEMBL1140374
Muscarinic acetylcholine receptor M5 Inhibition < 10.0 % Percent inhibition against Muscarinic acetylcholine receptor M5 at 1 uM CHEMBL1140374
Vesicular acetylcholine transporter Inhibition < 10.0 % Percent inhibition against Acetylcholine transporter at 1 uM CHEMBL1140374
Opioid receptors; mu/kappa/delta Inhibition < 10.0 % Percent inhibition against Opioid receptor at 1 uM CHEMBL1140374
Serotonin 1a (5-HT1a) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 1A receptor at 1 uM CHEMBL1140374
Serotonin 2a (5-HT2a) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 2A receptor at 1 uM CHEMBL1140374
Serotonin 2c (5-HT2c) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 2C receptor at 1 uM CHEMBL1140374
Serotonin 3 (5-HT3) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 3 receptor at 1 uM CHEMBL1140374
Serotonin 5a (5-HT5a) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 5A receptor at 1 uM CHEMBL1140374
Serotonin 6 (5-HT6) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 6 receptor at 1 uM CHEMBL1140374
Adenosine A1 receptor Ki = 26.2 nM Binding affinity towards human Adenosine A1 receptor expressed in CHO cells using 1 nM [3H]DPCPX CHEMBL1140374
Serotonin 4 (5-HT4) receptor Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine 4 receptor at 1 uM CHEMBL1140374
Norepinephrine transporter Inhibition < 10.0 % Percent inhibition against Norepinephrine transporter at 1 uM nonselective CHEMBL1140374
Dopamine transporter Inhibition < 10.0 % Percent inhibition against Dopamine transporter at 1 uM CHEMBL1140374
Serotonin transporter Inhibition < 10.0 % Percent inhibition against 5-hydroxytryptamine transporter at 1 uM nonselective CHEMBL1140374
Equilibrative nucleoside transporter 1 Inhibition = 34.0 % Percent inhibition against ADO transporter at 1 uM nonselective CHEMBL1140374
Adenosine receptors; A1 & A2a Selectivity = 7.84 Selective binding affinity towards human Adenosine A1 receptor expressed in CHO cells using [3H]DPCPX compared to human Adenosine A2a receptor expressed in HEK293 cells using [3H]-CGS-21,680 CHEMBL1140374
Adenosine A3 receptor Ki = 760.0 nM Binding affinity towards human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA CHEMBL1140374
Adrenergic receptor alpha-1 Inhibition < 10.0 % Percent inhibition against Alpha-1 adrenergic receptor at 1 uM CHEMBL1140374
Adrenergic receptor alpha-2 Inhibition < 10.0 % Percent inhibition against Alpha-2 adrenergic receptor at 1 uM CHEMBL1140374
Beta-1 adrenergic receptor Inhibition < 10.0 % Percent inhibition against Beta-1 adrenergic receptor at 1 uM CHEMBL1140374